The Scientist - Home

This postdoctoral researcher investigates how ovarian cancer cells survive immune attacks by macrophages during a destructive process called trogocytosis.

As conflicts escalate, resource shortages and patient safety force researchers in Middle Eastern countries to make difficult decisions about clinical trials.

This postdoctoral researcher investigates how injury-induced non-coding RNAs protect brain cells from damage after ischemic stroke.

Scientists are exploring why high temperatures may increase brain stroke risk, who is most at risk, and how the threat may grow in a warming world.

Thousands of cyclosporiasis cases across dozens of US states triggered investigations, but the exact contamination source remains elusive.

A new peptide-based vaccine elicited antigen-specific T cell responses in high-risk patients, demonstrating proof of concept for PDAC intervention. 

This postdoctoral researcher studies the complex structural domains of long non-coding RNAs to uncover targetable heterogeneities in breast cancer.

A new AAV-based gene therapy successfully improved seizures, behavior, and brain activity in fragile X syndrome mice, paving the way for clinical development.

Jennifer Doudna's new AI-designed CRISPR-Cas12 nuclease outperformed its natural counterpart.

Improving macrophage-mediated senescent neutrophil clearance in mice prevented age-related decline, offering potential targets for antiaging therapies.

A brain-computer interface paired with electrical stimulation patches helped a paralyzed man regain hand strength, dexterity, and his sense of touch.

Using a protein large language model, researchers reconstructed the T. rex collagen type 1 protein sequence, which they then expressed and manufactured into leather.